CLDX Celldex: Earnings per share for the last twelve months

Official company branding of Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX) revenues are volatile and depend on regulatory verdicts. The rolling annual EPS trend demonstrates current efficiency, where the -4.34 level represents the current value. Growth relies on exclusive, first-in-class mast cell inhibitors. Prospects are based on successful antibody tests against dermatitis, which enables the steady attraction of investment capital.

Celldex Therapeutics (CLDX) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/12/2026

Analytical breakdowns and data insights for company Celldex Therapeutics Inc (CLDX)

- current quotes and average value forecast:
Price Chart Celldex Therapeutics|CLDX - Consensus Target
- company stock capitalization data:
Market Value Celldex Therapeutics, Inc.|CLDX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Celldex Therapeutics|CLDX - Book Capitalization|Market Value to Book Value Ratio celldex.com|CLDX - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Celldex Therapeutics|CLDX - Long-Term Liabilities to Capital|Short-Term Debt to Capital Celldex|CLDX - Company Total Debt|Debts to Book Capitalization Celldex Therapeutics, Inc.|CLDX - Long-Term Debt|Company Short-Term Debt Celldex Therapeutics|Quick Liquidity celldex.com
- earnings and valuation multiples indicators:
CLDX - Company Net Income|Projected Future Earnings Celldex Therapeutics|CLDX - Price to Earnings Multiple|Forward P/E Multiple Celldex Therapeutics, Inc.|CLDX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Celldex Therapeutics, Inc.|CLDX - Operating profit before amortization|Net earnings per share for the last 12 months Celldex Therapeutics|CLDX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months celldex.com|CLDX - Net earnings per one share growth for the current year|Earnings growth forecast for next year Celldex Therapeutics
Initial company analysis:Celldex Therapeutics (CLDX)
Manufactured products of Celldex Therapeutics Inc

Due to its insulation from macroeconomic fluctuations and steady demand for innovative drugs, Celldex Therapeutics (CLDX) serves as a reliable defensive asset. The sliding earnings per share trend from GURU.Markets reflects the business's actual income, adjusted for issuance volume, allowing investors to track daily shifts in operational efficiency for timely portfolio rebalancing and the minimization of deep drawdown risks.

Main competitors

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Aurinia Pharmaceuticals Inc (AUPH) - Net earnings per one share for the last twelve months|BioCryst Pharmaceuticals Inc - Net earnings per share (EPS TTM)|Vera Corp (VERA) - Net earnings per share for the last 12 months|DNTH: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months pharvaris.com (PHVS)|Earnings per share for the last twelve months AbCellera Biologics Inc.|Earnings per share for the last twelve months TRML|Earnings per share for the last twelve months Intrexon (PGEN)|Earnings per share for the last twelve months PHAR (Pharming Corp)|Net earnings per share (EPS TTM) NKTR (Nektar Therapeutics)|UPB: Earnings per share for the last 12 months|Zenas Biopharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Immunome Inc|GOSS (Gossamer Corp) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months KALV|Net earnings per share for the last 12 months SEPN|PVLA: Earnings per share for the trailing year|Net earnings per share for the last 12 months SVRA (Savara)|Earnings per share for the last four quarters RIGL|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Earnings per share for the trailing year ATXS|enGene Holdings Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Earnings per share for the last twelve months|Aclaris Therapeutics Inc. - Earnings per share for the trailing year|KYTX (Kyverna) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tiziana Life Sciences, Ltd.|Earnings per share for the last twelve months Cabaletta Bio, Inc. (CABA)|VTYX: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) THTX (Theratechnologies)|Avalo Therapeutics, Inc. (AVTX) - Net earnings per one share for the last twelve months|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|CLYM (Climb Bio Inc) - Net earnings per share for the last 12 months|ZURA: Earnings per share for the last four quarters|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|Adagene Corp (ADAG) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last 12 months shattucklabs.com STTK|Earnings per share for the last twelve months Equillium EQ|Net earnings per share for the last four quarters Connect Biopharma Holdings (CNTB)|Immunic Inc - Net earnings per share (EPS TTM)|Atara Biotherapeutics (ATRA) - Net earnings per share for the last 12 months|inflarx.de (IFRX) - Earnings per share for the last twelve months|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CELU (Celularity Corp)|Net earnings per share for the last 12 months INMB (INmune Bio)|Barinthus Biotherapeutics PLC - Earnings per share for the last 12 months|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|SABS (SAB Biotherapeutics Inc) - Earnings per one share for the last 12 months|Akari Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ENLV (Enlivex Therapeutics)|QTTB: Net earnings per share (EPS TTM)|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Edesa|IBIO: Earnings per share for the trailing year|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|Net earnings per share for the last 12 months xtlbio.com XTLB|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share (EPS TTM) HCW Biologics, Inc. HCWB|APVO: Net earnings per share for the last 12 months|Earnings per share for the trailing year AIM (AIM ImmunoTech, Inc.)|ADTX: Net earnings per share (EPS TTM)|GRI - Net earnings per share for the last four quarters|Earnings per share for the last twelve months XORTX Therapeutics|Net earnings per share for the last 12 months Vyome Holdings Inc. (HIND)|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last 12 months Indaptus Corp INDP|Scinai Immunotherapeutics - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) CalciMedica Inc CALI|AFMD - Earnings per share for the last twelve months|ALLK (Allakos Inc.) - Earnings per share for the last 12 months|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences (IGMS)|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months oceanbiomedical.com (OCEA)|Net earnings per share (EPS TTM) TCBP|THRD - Net earnings per one share for the last twelve months